Given the severe shortfall of research scientists who are capable of conducting comprehensive studies that can translate fundamental knowledge from the bench to the clinical and the community settings for the improvement of cancer prevention and control, the purpose of this research training program is to provide integrated training in an inter-disciplinary research and teaching setting at the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center. Trainees will be trained in understanding the role of environmental exposures and genetic and other physiological factors in the development and progression of cancer in humans. The training program involves cross-disciplinary training courses in different tracks in the Clinical Trial Research, the Translational Research, and the Population-Based Observational and Interventional Research on cancer. Trainees will work with experienced mentors in a multiple disciplinary team conducting researches from mechanistic experiments and observational studies in populations to randomized intervention studies to test the efficacy of chemo- and immuno-preventive agents on cancer protection in humans. The mentored research will provide direct research experience to trainees in study design, methodological development, implementation of research protocol, data collection, analysis and interpretation, and manuscript preparation and publication. Trainees also will learn how to translate discoveries from pre-clinical experimental and/or observational studies into randomized interventional studies for cancer prevention. The unique training of this program will train next generation of scientists who can lead the cutting-edge translational research on cancer etiology and prevention. This training program is a joint effort of 23 preceptors who are conducting active research projects all with independent research funding in University of Pittsburgh. These faculties are from the following research programs: Cancer Epidemiology and Prevention Program; Breast and Ovarian Cancer Program; Biobehavioral Oncology Program; Cancer Immunology Program; Cancer Therapeutics Program; Head & Neck Cancer Program; Lung Cancer Program; and Molecular and Cellular Cancer Biology Program at the UPMC Hillman Cancer, a top-ranked Comprehensive Cancer Center with $94 million direct research funding in 2017. Trainees will receive cutting-edge translational research training and experience. We request continuing funding to support 3 postdoctorates and one predoctorate per year for 5 years. Our recent data on applicant recruitment, retention and training experience demonstrate a relatively large pool of candidates with high academic performance. In addition, we successfully enrolled one-third trainees from the underrepresented racial and ethnical groups. The progress and success of the training program will continue to track the career development and research activities of past trainees in the 10 years post-training.

Public Health Relevance

. This training program will create a new generation of researchers superbly trained in multidisciplinary settings with a broad perspective and knowledge concerning basic, epidemiologic and clinical sciences. This new generation of scientists will be competent to undertake multiple disciplinary etiologic and preventive research that translates the discoveries in pre-clinical experimental and observational studies into randomized interventional studies for Eliminating the Suffering and Death due to Cancer, the ultimate goal set forth by NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA186873-06
Application #
9630108
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
2014-08-05
Project End
2024-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15260
Pradhan-Sundd, Tirthadipa; Vats, Ravi; Russell, Jacquelyn O et al. (2018) Dysregulated Bile Transporters and Impaired Tight Junctions During Chronic Liver Injury in Mice. Gastroenterology 155:1218-1232.e24
Katz, Tiffany A; Wu, Anna H; Stanczyk, Frank Z et al. (2018) Determinants of prolactin in postmenopausal Chinese women in Singapore. Cancer Causes Control 29:51-62
Smith, Tracy T; Cassidy, Rachel N; Tidey, Jennifer W et al. (2017) Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial. Addiction 112:349-359
Rupprecht, Laura E; Smith, Tracy T; Donny, Eric C et al. (2017) Self-administered nicotine differentially impacts body weight gain in obesity-prone and obesity-resistant rats. Physiol Behav 176:71-75
Smith, Tracy T; Rupprecht, Laura E; Denlinger-Apte, Rachel L et al. (2017) Animal Research on Nicotine Reduction: Current Evidence and Research Gaps. Nicotine Tob Res 19:1005-1015
Eaglehouse, Yvonne L; Koh, Woon-Puay; Wang, Renwei et al. (2017) Physical activity, sedentary time, and risk of colorectal cancer: the Singapore Chinese Health Study. Eur J Cancer Prev 26:469-475
Tidey, Jennifer W; Cassidy, Rachel N; Miller, Mollie E et al. (2016) Behavioral Economic Laboratory Research in Tobacco Regulatory Science. Tob Regul Sci 2:440-451
Smith, Tracy T; Rupprecht, Laura E; Sved, Alan F et al. (2016) Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation. Psychopharmacology (Berl) 233:3953-3964
Rupprecht, Laura E; Smith, Tracy T; Donny, Eric C et al. (2016) Self-Administered Nicotine Suppresses Body Weight Gain Independent of Food Intake in Male Rats. Nicotine Tob Res 18:1869-1876
Henningfield, Jack E; Smith, Tracy T; Kleykamp, Bethea A et al. (2016) Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research. Psychopharmacology (Berl) 233:3829-3848

Showing the most recent 10 out of 13 publications